What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Andrew V. Biankin spends much of his time researching Pancreatic cancer, Cancer, Cancer research, Genetics and KRAS.
His Pancreatic cancer research is multidisciplinary, incorporating elements of Adenocarcinoma, Pancreas, CDKN2A, Metastasis and Immunotherapy.
His research investigates the connection with Cancer and areas like Bioinformatics which intersect with concerns in MEDLINE and Computational biology.
His Cancer research study integrates concerns from other disciplines, such as Carcinogenesis, Personalized medicine, PDGFRB and Biomarker.
His study in KRAS is interdisciplinary in nature, drawing from both Transcriptome, Regulation of gene expression and Proteomic Profiling.
His Human genome research includes themes of Breast cancer, Human genetics, Systems biology and Genomics.
His most cited work include:
- Signatures of mutational processes in human cancer (5372 citations)
- International network of cancer genome projects (1611 citations)
- International network of cancer genome projects (1611 citations)
What are the main themes of his work throughout his whole career to date?
Andrew V. Biankin mainly investigates Pancreatic cancer, Cancer research, Internal medicine, Cancer and Oncology.
His studies in Pancreatic cancer integrate themes in fields like Bioinformatics, Pancreas, Disease, Pathology and Gemcitabine.
In his study, Gene expression is strongly linked to Carcinogenesis, which falls under the umbrella field of Cancer research.
His Internal medicine research includes elements of Gastroenterology, Endocrinology and Surgery.
Cancer is a subfield of Genetics that Andrew V. Biankin studies.
His Oncology study incorporates themes from Biomarker, CA19-9 and Pancreatic ductal adenocarcinoma.
He most often published in these fields:
- Pancreatic cancer (82.43%)
- Cancer research (51.24%)
- Internal medicine (42.57%)
What were the highlights of his more recent work (between 2017-2021)?
- Pancreatic cancer (82.43%)
- Cancer research (51.24%)
- Cancer (48.51%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Pancreatic cancer, Cancer research, Cancer, Internal medicine and Oncology.
His Pancreatic cancer research is multidisciplinary, relying on both Molecular pathology, Pancreas, Disease, Biomarker and Gemcitabine.
The Cancer research study combines topics in areas such as Stroma, DNA damage, Transcriptome, Immune system and In vivo.
His Cancer research integrates issues from Keratin 17, Genome and Bioinformatics.
His research integrates issues of Exome sequencing, Exome and Genetic heterogeneity in his study of Bioinformatics.
His work in the fields of Internal medicine, such as Adenocarcinoma and Biopsy, intersects with other areas such as Text mining and Subtyping.
Between 2017 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Molecular subtypes of pancreatic cancer (165 citations)
- Molecular subtypes of pancreatic cancer (165 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Andrew V. Biankin mostly deals with Pancreatic cancer, Cancer, Oncology, Internal medicine and Cancer research.
His work carried out in the field of Pancreatic cancer brings together such families of science as Molecular pathology, Bioinformatics, Pancreas, Disease and Gemcitabine.
His Cancer study combines topics in areas such as Precision medicine and Cancer genome.
His Oncology study integrates concerns from other disciplines, such as Biomarker, Open label, Nab-paclitaxel and Adenocarcinoma.
His work deals with themes such as Exome sequencing, Exome, Metastatic pancreatic cancer and Genetic heterogeneity, which intersect with Adenocarcinoma.
His studies in Cancer research integrate themes in fields like Pancreatic tumor, Stroma, Tumor microenvironment, Immune system and Phenotype.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
